hydrogen sulfide has been researched along with Atrial Fibrillation in 5 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Excerpt | Relevance | Reference |
---|---|---|
"Hydrogen sulfide (H2S) has drawn considerable attention in recent years for its potential as a cardiovascular protector." | 5.56 | Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway. ( Ling, X; Sun, J; Wang, P; Xi, W; Xiao, J; Xue, X; Yang, Q, 2020) |
"Hydrogen sulfide (H2S) has drawn considerable attention in recent years for its potential as a cardiovascular protector." | 1.56 | Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway. ( Ling, X; Sun, J; Wang, P; Xi, W; Xiao, J; Xue, X; Yang, Q, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Al-Owais, MM | 1 |
Hettiarachchi, NT | 1 |
Dallas, ML | 1 |
Scragg, JL | 1 |
Lippiat, JD | 1 |
Holden, AV | 1 |
Steele, DS | 1 |
Peers, C | 1 |
Xue, X | 1 |
Ling, X | 1 |
Xi, W | 1 |
Wang, P | 1 |
Sun, J | 1 |
Yang, Q | 1 |
Xiao, J | 1 |
Watts, M | 1 |
Kolluru, GK | 1 |
Dherange, P | 1 |
Pardue, S | 1 |
Si, M | 1 |
Shen, X | 1 |
Trosclair, K | 1 |
Glawe, J | 1 |
Al-Yafeai, Z | 1 |
Iqbal, M | 1 |
Pearson, BH | 1 |
Hamilton, KA | 1 |
Orr, AW | 1 |
Glasscock, E | 1 |
Kevil, CG | 1 |
Dominic, P | 1 |
Su, H | 2 |
Liu, CH | 1 |
Hu, HJ | 1 |
Zhao, JB | 1 |
Zou, T | 1 |
Tang, YX | 1 |
KREKEL, K | 1 |
5 other studies available for hydrogen sulfide and Atrial Fibrillation
Article | Year |
---|---|
Inhibition of the voltage-gated potassium channel Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling.
Topics: Atrial Fibrillation; HEK293 Cells; Humans; Hydrogen Sulfide; Kv1.5 Potassium Channel; Myocytes, Card | 2023 |
Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway.
Topics: Animals; Atrial Fibrillation; Cell Culture Techniques; Diabetes Mellitus, Experimental; Disease Mode | 2020 |
Decreased bioavailability of hydrogen sulfide links vascular endothelium and atrial remodeling in atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Biological Availability; Case-Control Studies; Endo | 2021 |
H
Topics: Angiotensin II; Atrial Fibrillation; Base Sequence; Connective Tissue Growth Factor; Fibroblasts; Fi | 2021 |
[ECG CHANGES AFTER HYDROGEN SULFIDE POISONING IN 2 WORKERS].
Topics: Atrial Fibrillation; Electrocardiography; Hydrogen Sulfide; Occupational Medicine; Poisoning; Sulfid | 1964 |